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ABSTRACT
The goal of this study was to identify BPD markers by gene expression profiling in lung and peripheral
blood mononuclear cell (PBMC) gene expression data. Studies of BPD are often focused on lung tissue,
but rarely venture to find markers of the disease outside of the most affected tissue. Genes identified
from these analyses can be used as markers of BPD, and may also be linked with causal mechanisms of
the disease. First, we tested the biological relevance of BPD biomarkers previously identified in lung
tissue by assessing their importance in normal lung development. Next, we identified sets of
differentially expressed genes at 5±2 days (Near-birth) and 25±3 days (Near-diagnosis) post birth within
a publicly-available microarray dataset utilizing RNA from the PBMCs from infants at high risk for a
diagnosis of BPD. These lists provided markers of BPD including ARGl, MPO, OLFM4, CEACAMl,
CEACAM6 and CEACAM8 that may provide further insight into the physiology of infants with BPD. Of
these, ARGl, CEACAMl and CEACAM6 were validated by qPCR using RNA samples from lung tissue. The
identified genes and their associations with the inflammatory response and vascular development via
the Urea cycle provide a basis for further investigation of these pathways within BPD
pathogenesis. Another benefit of these markers has been explored: using PBMC gene expression to
predict long-term outcome in the near-birth time point. These studies showed that a simple 3-fold
cross-validation technique could provide a model with nearly 73% accurate classification of infants at
less than 1 week after birth. These studies provide a strong motive for further analyses of these genes
of interest and the predictive ability of biomarkers of BPD in PBMCs.

1

3.2.0 Specific Aim 2
The goal of this aim was to identify gene expression biomarkers of BPD in peripheral blood. These
studies focused on a 300 sample data set obtained from the GEO, describing gene expression in
peripheral blood mononuclear cells obtained from premature infants with or without a diagnosis of BPD.
Blood samples were obtained from 111 subjects that are at risk for BPD at three distinct time-points. Of
those, 68 {61%) were eventually diagnosed with BPD. After data preparation, expression values were
examined in order to identify genes associated with BPD at each of the three time points, as well as
across all three. Select markers were validated by multiple methods.

4.0.0 METHODS AND RESULTS
4.1.0 Specific Aim 1
Though there are relatively few datasets available for this investigation of BPD, those that are available
have the potential to be quite informative (Table 1). Among the available datasets, many have been
generated by the Mariani lab at the University of Rochester Medical Center. Two of these datasets were
generated with human lung tissues using Affymetrix Human Genome U133plus 2.0 microarrays. Kho et.
al. {2010) identified genes as significant during human lung development by gene expression analysis
(15). This data set is from normal human lung tissue samples that cover 38 unique time points from
pseudoglandular and early canalicular stages of lung development (15). The Bhattacharya 2012 data set,
consisting of 11 BPD lung tissues, 9 non-lung disease tissues and 8 tissues from non-BPD lung diseases, is
the other{16).
In addition, the Mariani lab has generated a number of murine lung tissue studies, either describing
normal lung development {15, 17) or newborn chronic lung disease (10). These data can be used to
determine genes of interest within lung tissue through analyses and comparison with the human
datasets. The normal mouse lung development dataset (Bonner 2003) consists of 16 embryonic and 12
post-birth samples, with 4 samples at 1, 2 and 4 weeks post birth. The datasets produced by Srisuma
(2010) contain three samples from each mouse genotype (FGF KO or WT) at 1 day and 1 week post birth,
as well as 3 FGF KO samples and 2 WT samples at 1 month post birth.
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Appendix A: A,B Signal density histograms and hierarchical clusters for PLIER and RMA normalized near-birth samples, respectively. C,D Signal density
histograms and hierarchical clusters for PLIER and RMA normalized near-diagnosis samples, respectively
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